Last reviewed · How we verify

Charcotrace Inj. — Competitive Intelligence Brief

Charcotrace Inj. (Charcotrace Inj.) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neurology / Diagnostic Imaging.

phase 3 Neurology / Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Charcotrace Inj. (Charcotrace Inj.) — Hanlim Pharm. Co., Ltd.. Charcotrace is a diagnostic imaging agent used to visualize and trace neural pathways and lesions in the central and peripheral nervous system.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Charcotrace Inj. TARGET Charcotrace Inj. Hanlim Pharm. Co., Ltd. phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Charcotrace Inj. — Competitive Intelligence Brief. https://druglandscape.com/ci/charcotrace-inj. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing